There is increasing agreement that electronic health records (EHRs) in office practice are an essential component in improving quality while reducing cost in the United States. However, there is no consistent, strong evidence that EHRs alone improve quality and outcomes. Several studies suggest that care for chronic diseases such as diabetes is no better and sometimes worse for clinicians who use an EHR. 1, 2 One reason could be that many clinicians have used EHRs mainly to improve documentation and billing rather than to improve quality of care. In order to facilitate the dissemination of EHRs in a way that is likely to improve quality, the Centers for Medicare & Medicaid Services (CMS) has required that clinicians demonstrate "meaningful use" (MU) of EHRs before receiving incentive payments.
So, it is logical to ask whether quality of care is improved when clinicians fulfill the requirements of MU, or stated otherwise, "is meaningful use really meaningful?" The article by Kern and colleagues in this issue of AJMQ (30 [6] :512-519) suggests that the answer is no, at least not yet. This prospective cohort study compared quality of care for 514 primary care physicians in New York State from 2010 to 2011. They found no difference in quality measures between those who achieved stage 1 MU and those who were using EHRs but had not achieved MU. These findings may provide fodder for those who argue that the large federal investment in MU was not worthwhile.
But before we jump to those conclusions, we must examine the reasons why MU may not have led to improved quality of care. First, as recognized by the authors, this study examined the effect of only the first stage of MU. As the authors state, this stage was designed to begin the MU process by facilitating the electronic capture of clinical data elements, while future stages of MU (stages 2 and 3) are designed to enable advanced clinical processes so as to improve outcomes. So what are these advanced clinical processes and how might they improve outcomes?
One important process is clinical decision support (CDS). CDS is defined as systems that "provide clinicians, staff, patients, and other individuals with knowledge and person-specific information, intelligently filtered and presented at appropriate times, to enhance health and health care." 3 CMS has recognized the importance of CDS in MU of EHRs, particularly in the third stage of MU.
But simply having CDS as part of an EHR may not be enough to improve quality. Although studies have generally shown CDS to improve preventive care services, 4, 5 the results for chronic disease management have been mixed, with improvements in testing but not in patient outcomes. 6, 7 One reason could relate to how CDS is incorporated into the office workflow. Creating "pop-ups" that are directed to the clinician in the middle of a visit may not be an effective use of CDS. A better way may be to direct messages to nonclinician staff who address issues before the clinician sees the patient. For example, when a patient with diabetes is seen for diabetes care or for another problem such as a back strain, a staff member can examine whether the patient is up-to-date on diabetes care. If the patient is in need of tests such as a lipid panel, staff are empowered to order the test according to standing orders before the patient is seen by the clinician. This "teambased" approach is consistent with the patient-centered medical home (PCMH) model of care. The PCMH model also encourages care management outside of office visits, which also can be facilitated by CDS. For example, staff can use CDS systems to run reports for patients who are not at their lipid goal. These patients can be contacted to arrange care, which can be done via electronic communication. In fact, electronic communication via a patient portal is another of the advanced clinical processes that are required in stages 2 and 3 of MU.
So, these EHR-based CDS may work best when used in a PCMH model of care so it can facilitate optimal performance by each member of the health care team. Actually, the Kern et al study included practices that had achieved PCMH recognition, but this article did not report on whether MU achievement had a positive impact on quality specifically for those practices. A current randomized study in Delaware is examining whether EHRbased CDS has a positive impact on diabetes quality specifically for small primary care practices that are 567433A JMXXX10.1177/1062860614567433American Journal of Medical QualityGill working in a PCMH model. 8 Some early findings from that project include challenges to incorporating CDS into clinical practice. For example, successful CDS requires that quality measures are captured as structured data fields, which requires customization not only of the EHR but also of the clinical workflow. The funding provided by CMS for MU is not enough to implement most basic EHR systems, let alone to add advanced features such as CDS and patient portals, and to pay for the staff and expertise needed to optimally incorporate these into the office workflow. Lack of data standardization is challenging not only within the offices; it is even more challenging to collate data across multiple offices using different EHRs, which is essential to the success of larger organizations such as accountable care organizations (ACOs).
Moving to a PCMH model that can work in tandem with EHRs also requires additional staffing; although some payers provide extra reimbursement for PCMHs, such funding is usually far below what is required to implement and sustain a PCMH. 9 The lack of funding for advanced features of EHRs and for PCMH is particularly difficult for small independent practices and may be one reason that physicians are moving from independent practices toward hospital employment. Some might argue that consolidation may be one way to more easily share data across ACOs and the health care system. But this consolidation may not be good for the US health system, because hospital-based practices are usually more costly than independent practices. 10 It would be better to develop policies that can help independent practices incorporate the advanced features of EHRs and share data with other components of the health system, so as to take advantage of the cost savings associated both with data sharing and with independent practice.
It is unlikely that CMS will provide additional funding for advanced EHR features, given federal budget limitations and Congressional gridlock. However, an upcoming Medicare initiative that may help is payment of a monthly care management fee for patients with 2 or more chronic conditions. 11 The amount being proposed as payment ($42 per patient per month) is significant enough to help fund the implementation and customization of advanced features such as CDS and patient portals as well as the staff needed to use these features for optimal chronic care management. Because the quality and cost benefits would accrue to payers and purchasers and to the larger health care system, it also would make sense for managed care organizations and other private payers to join Medicare in providing this level of funding for chronic care management, or to pick up where CMS is leaving off in MU funding by providing additional funding for advanced EHR features.
In conclusion, the article by Kern et al shows that at the current stage of implementation, MU is not particularly meaningful. However, these early stages of EHR implementation should be viewed only as providing the foundation on which more advanced features can be built. It is these advanced features that can facilitate the processes of care coordination and chronic disease management that are essential to improving quality and reducing costs. But practices need financial support to make it feasible and worthwhile to incorporate these advanced features. Managed care organizations and other private payers should follow the lead of CMS by providing funding to support the full cost of these features. This support could help ensure that EHRs fulfill their promise of improving quality while reducing cost.
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